Goldman Sachs Resumes Coverage on SXC Health Solutions (SXCI) at Buy; Strong Growth Beyond Integration
Tweet Send to a Friend
Goldman Sachs resumes coverage on SXC Health Solutions (NASDAQ: SXCI) with a Buy. PT $120.00.
Analyst, Robert P. Jones ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Robert P. Jones ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


